Bristol Myers, Pfizer to sell blood thinner Eliquis directly to US patients
The initiative is targeted at the small percentage of patients on Eliquis who are uninsured or underinsured, and health pricing experts cautioned that the discounted price might still be too high for many of those consumers.
The program - which would bypass traditional pharmacy benefit managers and insurers - offers a roughly 43% discount from the list price, cutting the treatment's monthly cost from around $606 to $346. But it would still cost more than 9 times the average out-of-pocket cost paid by commercially insured patients.
The new discounted price is also significantly higher than the $231 per month Medicare price that former President Joe Biden's administration negotiated under the Inflation Reduction Act, which is set to take effect next year, and the price of the drug abroad.
"This discount is not as meaningful as that delivered through the IRA negotiations - those discounts have been ridiculed by Trump as not meaningful, so there's potential for skepticism from the administration on this offer," Bernstein analyst Courtney Breen said in a note.
The Trump administration has ramped up efforts to tackle high U.S. prescription drug prices through a "most-favored-nation" (MFN) policy, aiming to align domestic prices with the lowest levels paid by comparable high-income countries.
According to a 2024 report from the Senate's Health, Education, Labor and Pensions committee, the cost of Eliquis was around $55 a month in France and $65 a month in the UK and Germany.
"These prices aren't really a good deal for most consumers," Stacie Dusetzina, professor at Vanderbilt University Medical Center, said, adding that patients without health insurance are generally less able to shoulder high out-of-pocket costs for drugs than those who are insured.
"We know that once patients have to pay more than $100 out-of-pocket, they are much more likely not to fill their prescriptions," she added.
Eligible patients will be able to buy the drug directly through the Eliquis 360 Support program from September 8.
Since its launch, Eliquis has been prescribed to over 15 million Americans and in 2024 it generated about $11.4 billion in global revenue.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
an hour ago
- The Independent
Warning issued for common artificial sweetener that can interfere with cancer treatments
A popular sugar substitute may interfere with certain cancer treatments, according to new research. The University of Pittsburgh and UPMC Hillman Cancer Center have released new research suggesting that using sucralose — a popular sugar replacement used by those trying to lose weight or manage their blood sugar levels — may make it harder to the body to respond to certain cancer treatments. According to the research, patients with melanoma and non-small cell lung cancer who consumed high levels of sucralose responded worse to immunotherapy and had worse survival rates than individuals whose diets had low levels of the artificial sweetener. The research also revealed a potential pathway for counteracting the potential negative effects of sucralose. The researchers found supplements that boost the levels of amino acid arginine actually counteracted the negative effects of the sweetener on immunotherapy treatments in mice. That approach could be pursed in further clinical trials to see if it can be used in humans. Doctor Abby Overacre, assistant professor in the Department of Immunology at the University of Pittsbugh and UPMC Hillman said in a statement that finding ways around forcing dietary changes is a worthwhile course of action, especially for cancer patients who are already dealing with the burden of the disease. 'It's easy to say, 'Stop drinking diet soda,' but when patients are being treated for cancer, they are already dealing with enough, so asking them to drastically alter their diet may not be realistic,' she said. 'We need to meet patients where they are. That's why it's so exciting that arginine supplementation could be a simple approach to counteract the negative effects of sucralose on immunotherapy.' The study, which used testing on mice, found the negative effects were potentially caused by disruption to gut bacteria by the artificial sweetener. It found that sucralose caused a shift in the composition of the gut bacteria in mice which allowed for an increase in bacteria that degrade arginine. The increased arginine resulted in reduced levels of the amino acid in blood, tumor fluid, and stool. 'When arginine levels were depleted due to sucralose-driven shifts in the microbiome, T cells couldn't function properly,' Overacre said. 'As a result, immunotherapy wasn't as effective in mice that were fed sucralose.' Diwakar Davar, associate professor of medicine at the University of Pittsburgh and a medical oncologist and hematologist at UPMC Hillman, was a collaborator on the study and noted that the negative effects of sucralose was consistent across a range of treatments for a variety of cancer types and stages. He said that prebiotic supplements could theoretically be developed specifically for cancer patients with high levels of sucralose in their blood to help mitigate the negative effects. The researchers hope to pursue a clinical trial to determine whether or not boosting arginine through supplements will counteract the effects of the sucralose. They also plan to expand their research to look at the effects of other artificial sweeteners — such as aspartame, saccharin, xylitol, and stevia — on the immune system and on cancer treatments.
The Sun
an hour ago
- The Sun
Almost one million NHS ‘free passes' handed out to asylum seekers
ALMOST one million NHS 'free passes' have been handed to asylum seekers in five years, stats reveal. Some 920,199 HC2 certificates — granting free prescriptions, dental care, eye tests, wigs and travel to appointments — were issued. That is 59 per cent of all HC2 forms dished out from 2019 to 2024, despite asylum seekers making up less than one per cent of the population. Shadow Home Secretary Chris Philp said: 'No wonder illegal immigrants from across Europe are flocking here.' The certificates include up to £233 for specs and unlimited dental work. Anyone can apply if they have little or no income. Asylum seekers automatically receive one if they qualify for Section 95 support, which covers housing and financial help. An NHS spokesman said: 'The NHS is legally required to provide healthcare services to asylum seekers, including access to help with health costs through the NHS Low Income Scheme.' A Government spokesman said most were issued 'under the previous administration'. The figures were uncovered via a Freedom of Information request to the NHS Business Services Authority. 25K migrants have arrived across the Channel so far this year despite Labour's promise to crackdown 1
Reuters
an hour ago
- Reuters
Trump administration blocks funding for CDC health programs, WSJ reports
Aug 1 (Reuters) - U.S. President Donald Trump's administration is blocking funding for a swath of public-health programs run by the Centers for Disease Control and Prevention, the Wall Street Journal reported on Friday, citing unnamed sources. These include youth violence prevention programs, research on preventing gun injuries and deaths and efforts targeting diabetes, chronic kidney disease and tobacco use, according to the report. The money withheld could not be determined, but it could be as high as $200 million, the WSJ reported, citing a person familiar with the matter. The CDC did not immediately respond to a Reuters request for comment. The White House has previously stated its intention to reduce U.S. health spending by more than a quarter next year, with the National Institutes of Health and the Centers for Disease Control and Prevention facing the brunt of billions of dollars in cuts. Earlier this week, Susan Monarez was confirmed as CDC director to lead a downsized agency as the White House moves to slash its budget by nearly $3.6 billion, reducing it to about $4 billion. The cuts follow a layoff plan enacted by U.S. Health Secretary Robert F. Kennedy Jr. that eliminated 2,400 positions in CDC, though roughly 700 of those workers have since been rehired.
